We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Personalized Treatment Trial for Breast Cancer Launched

This trial is important because it is one of the first to examine a methodology for personalizing cancer treatment.
News

FDA Grants Biovest International Fast Track Status for BiovaxID™

Biovest is now eligible to submit a biologics license application (BLA) on a rolling basis.
News

Clinical Development Program Utilizing Xenomics' DNA-Based Diagnostic Technology is Ranked Best in Europe

European Consortium led By Xenomics' collaborative venture with leading European research center prepares for euro 2 million funding of tuberculosis clinical program.
News

RCP Diagnostics Licenses Its Protein Marker to Biomarker Technologies

Biomarker will use the RCP marker only for the diagnosis of breast cancer.
News

J. Brian Munroe Elected President and Chairman of Personalized Medicine Coalition

Newly appointed vice president of WellPoint brings important payer constituency into coalition.
News

GeneGo and XB TransMed Provide Integrated Solutions to the Translational Medicine Market

XB-BIS integration with the MetaCore™ permits the user to integrate back and forth between expanding knowledge and enhanced application.
News

Scientists Develop Concept with Potential to Help Predict how Individuals may Respond to Drugs

The method is expected to be synergistic with existing pharmacogenomic approaches.
News

Dalton Pharma Services Announces Completion of its GMP Oligonucleotide Manufacturing Facility

Building on its 17 year history in oligonucleotide manufacture and analysis, Dalton can now use its expertise in synthesis and manufacturing of antisense oligonucleotides.
News

bmd Obtains FDA Approval for Four new FIDIS™ Diagnostic Kits for Autoimmune Diseases

Approval of FIDIS Connective 10, Vasculitis, Celiac IgC and Celiac IgA will boost bmd's penetration of the North American market
News

Expanded Access Program for Rexin-G™ Provides Genetic Medicine to Cancer Patients

The Expanded Access Program extends the clinical applications of the world's first targeted genetic medicine to many more cancer patients.
Advertisement